Showing results (1411-1420 of 2,643) with videos related to
Sort By:
Pageof 265
Hematology (Amsterdam, Netherlands)|April 2, 2013
Methylation status of CEBPA gene promoter in chronic myeloid leukemiaSandhya Annamaneni, Sailaja Kagita, Manjula Gorre, et al.Hematology (Amsterdam, Netherlands)|April 2, 2013
The evaluation of iron overload through hepcidin level and its related factors in myelodysplastic syndromesShucheng Gu, Xiaoli Song, Youshan Zhao, et al.Hematology (Amsterdam, Netherlands)|June 6, 2013
Plasma PTX3 levels in sickle cell disease patients, during vaso occlusion and acute chest syndrome (data from Saudi population)Shereen A Elshazly, Nihal M Heiba, Waleed M AbdelmageedHematology (Amsterdam, Netherlands)|May 3, 2012
Measurement of Th1, Th2 cytokines and white cell count in childhood haemoglobinopathies with uncomplicated malaria infectionY M Tatfeng, D E Agbonlahor, O F AmegorHematology (Amsterdam, Netherlands)|October 22, 2009
Relationship between expression of mutant type glutathione S-transferase theta-1 gene and reactivity of rapamycin in myelodysplastic syndromeYasuhiro Maeda, Terufumi Yamaguchi, Atsushi Sasakawa, et al.Hematology (Amsterdam, Netherlands)|October 22, 2009
Histiocytosis disorders in Northeast Egypt: epidemiology and survival studies (a 5-year study)Youssef A Al-Tonbary, Mohamed M Sarhan, Ahmed K Mansour, et al.Hematology (Amsterdam, Netherlands)|October 22, 2009
Antiplatelet antibodies contribute to thrombocytopenia associated with chronic hepatitis C virus infectionSalah Aref, Tarek Sleem, Nadia El Menshawy, et al.Hematology (Amsterdam, Netherlands)|November 28, 2009
Frequency and prognostic significance of murine double minute protein-2 overexpression and p53 gene mutations in childhood acute lymphoblastic leukemiaOlfat M Hendy, Doaa M Elghannam, Jehan A El-Sharnouby, et al.Hematology (Amsterdam, Netherlands)|November 28, 2009
Elevated platelet microparticle levels in valvular atrial fibrillationHanan Azzam, Maged ZagloulHematology (Amsterdam, Netherlands)|November 28, 2009
Clinical significance of V617F mutation of the JAK2 gene in patients with chronic myeloproliferative disordersAna L Basquiera, Néstor W Soria, Ricardo Ryser, et al.Pageof 265